18-Hydroxy-11-deoxycorticosterone (18-OH-DOC) secretion in experimental and human hypertension.
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D003480:Cushing Syndrome / Q000503:physiopathology; D003907:Dexamethasone / Q000494:pharmacology; D004032:Diet; D004285:Dogs; D005260:Female; D006801:Humans; D006889:Hydroxycorticosteroids / Q000378:metabolism* / Q000652:urine; D006929:Hyperaldosteronism / Q000503:physiopathology; D006973:Hypertension / Q000503:physiopathology*; D007553:Isotope Labeling; D007664:Ketosteroids / Q000378:metabolism / Q000652:urine; D008297:Male; D008722:Methods; D011278:Pregnanes / Q000378:metabolism* / Q000652:urine; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D013250:Steroid Hydroxylases / Q000037:antagonists & inhibitors; D014316:Tritium
D006889:Hydroxycorticosteroids; D007664:Ketosteroids; D011278:Pregnanes; D014316:Tritium; D000804:Angiotensin II; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D012964:Sodium; D013250:Steroid Hydroxylases